Biotron is preparing a ***detailed briefing package to submit to the FDA during the first quarter of 2022.
Guidance from the FDA will inform the final design of a suitable international trial and will be a key
component of outreach to **potential partners.
**potential partners are what they have been ....
*** they're preparing detailed package in that they're confident to move forward with FDA guidance...
Biotron's Phenomenal Success ..., page-3
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.62M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.4¢ | $1.152K | 21.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 87420 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 98690 | 1 |
View Market Depth
| Last trade - 10.13am 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.5¢ |
Change
0.000 ( 1.79 %) |
||||
| Open | High | Low | Volume | ||
| 5.5¢ | 5.5¢ | 5.5¢ | 4000 | ||
| Last updated 10.06am 06/06/2024 ? | |||||
| BIT (ASX) Chart |